Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Rigel Pharmaceuticals Inc (RIGL)  
$1.49 0.07 (4.93%) as of 4:30 Wed 3/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 168,980,000
Market Cap: 251.78(M)
Last Volume: 681,282 Avg Vol: 2,809,258
52 Week Range: $0.7224 - $1.82
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Rigel Pharmaceuticals is a biotechnology company focused on discovering, developing and providing small molecule drugs that improve the lives of patients with hematologic disorders, cancer and rare immune diseases. Co.'s U.S. Food and Drug Administration approved product is TAVALISSE® (fostamatinib disodium hexahydrate) tablets, an oral spleen tyrosine kinase inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The product is also commercially available in Europe, the U.K. (TAVLESSE) and Canada (TAVALISSE) for the treatment of chronic immune thrombocytopenia in adult patients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,000,000
Total Buy Value $0 $0 $0 $688,400
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 80,041 80,041 80,041 116,547
Total Sell Value $90,916 $90,916 $90,916 $153,348
Total People Sold 3 3 3 4
Total Sell Transactions 6 6 6 10
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 318
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Schorno Dean L EVP & Chief Financial Officer   •       •      –    2024-02-05 4 S $1.14 $8,011 D/D (7,027) 402,891 -21%     
   Rodriguez Raul R CEO, President   •       •      –    2024-02-05 4 S $1.14 $34,821 D/D (30,545) 2,036,629 -21%     
   Santos David A EVP, Chief Commercial Officer   •       •      –    2024-02-05 4 S $1.14 $10,167 D/D (8,918) 349,093 -21%     
   Schorno Dean L EVP & Chief Financial Officer   •       •      –    2024-02-02 4 S $1.13 $6,327 D/D (5,601) 409,918 -25%     
   Rodriguez Raul R CEO, President   •       •      –    2024-02-02 4 S $1.13 $25,261 D/D (22,349) 2,067,174 -25%     
   Santos David A EVP, Chief Commercial Officer   •       •      –    2024-02-02 4 S $1.13 $6,329 D/D (5,601) 358,011 -25%     
   Rodriguez Raul R CEO, President   •       •      –    2024-01-23 4 A $0.00 $0 D/D 400,000 2,089,523     -
   Furey Raymond J. EVP, GC, CCO & Corp Sec   •       •      –    2024-01-23 4 A $0.00 $0 D/D 209,000 214,000     -
   Santos David A EVP, Chief Commercial Officer   •       •      –    2024-01-23 4 A $0.00 $0 D/D 209,000 363,612     -
   Schorno Dean L EVP & Chief Financial Officer   •       •      –    2024-01-23 4 A $0.00 $0 D/D 209,000 415,519     -
   Lapointe Gregg Anthony   •       •      –    2023-05-26 4 A $0.00 $0 D/D 25,000 75,000     -
   Lyons Gary A   •       •      –    2023-05-26 4 A $0.00 $0 D/D 25,000 75,000     -
   Moos Walter H   •       •      –    2023-05-26 4 A $0.00 $0 D/D 25,000 77,222     -
   Kotzin Brian L.   •       •      –    2023-05-26 4 A $0.00 $0 D/D 25,000 75,000     -
   Ali-Jackson Kamil   •       •      –    2023-05-26 4 A $0.00 $0 D/D 25,000 43,750     -
   Hannah Alison L.   •       •      –    2023-05-26 4 A $0.00 $0 D/D 25,000 56,250     -
   Wasman Jane   •       •      –    2023-05-26 4 A $0.00 $0 D/D 25,000 75,000     -
   Rodriguez Raul R CEO, President   •       •      –    2023-02-06 4 S $1.75 $35,595 D/D (20,340) 1,680,713 4%     
   Dummer Wolfgang EVP & CMO   •       •      –    2023-02-02 4 S $1.66 $8,946 D/D (5,389) 72,459 10%     
   Santos David A EVP, Chief Commercial Officer   •       •      –    2023-02-02 4 S $1.66 $8,945 D/D (5,388) 144,612 10%     
   Schorno Dean L EVP & Chief Financial Officer   •       •      –    2023-02-02 4 S $1.66 $8,946 D/D (5,389) 196,519 10%     
   Rodriguez Raul R CEO, President   •       •      –    2023-01-26 4 A $0.00 $0 D/D 300,000 1,701,053     -
   Schorno Dean L EVP & Chief Financial Officer   •       •      –    2023-01-26 4 A $0.00 $0 D/D 63,000 201,908     -
   Santos David A EVP, Chief Commercial Officer   •       •      –    2023-01-26 4 A $0.00 $0 D/D 80,000 150,000     -
   Rodriguez Raul R CEO, President   •       •      –    2022-06-09 4 B $0.69 $688,400 D/D 1,000,000 1,391,776 2.81 14%     

  318 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed